← Back to Search

Other

BTL-785-7 Treatment for Wrinkles

N/A
Recruiting
Research Sponsored by BTL Industries Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

This trial will test a new, non-invasive system for treating facial wrinkles. The safety and performance of the system will be evaluated.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Skin Wrinkling
Secondary outcome measures
Evaluation of skin quality and aesthetic changes of the treated areas after the therapies
Subject Satisfaction
Therapy Comfort

Trial Design

1Treatment groups
Experimental Treatment
Group I: BTL-785-7 TreatmentExperimental Treatment1 Intervention
Treatment with the BTL-785-7 applicator to the BTL-785F system.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BTL-785-7 Treatment
2022
N/A
~20

Find a Location

Who is running the clinical trial?

BTL Industries Ltd.Lead Sponsor
51 Previous Clinical Trials
1,780 Total Patients Enrolled
12 Trials studying Wrinkles
355 Patients Enrolled for Wrinkles

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research include participants who are of legal age?

"According to the guidelines of this medical trial, 21 is the least permissible age for qualification and 70 years old is the upper limit."

Answered by AI

Who would be an ideal candidate for this clinical experiment?

"This trial is currently accepting applications from individuals between 21 and 70 years old who have visible signs of wrinkles. Approximately 22 people will be admitted to the study."

Answered by AI

Is the enrollment phase of this experiment still open?

"The trial is ongoing, with records on clinicaltrials.gov dating back to June 6th 2022 and showing the latest amendment made on September 1st 2022. This study seeks enrolment from potential participants."

Answered by AI

What is the current enrollment level for this clinical investigation?

"Affirmative. According to the data accessible on clinicaltrials.gov, this study is currently accepting participants; it was initially posted on June 6th 2022 and most recently modified September 1st 2022. The investigation requires 22 individuals at 2 separate facilities."

Answered by AI
~8 spots leftby Apr 2025